A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients / Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 19:(2008), pp. 769-773. [10.1093/annonc/mdm560]
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
ZINZANI, PIER LUIGI;TANI, MONICA;FANTI, STEFANO;STEFONI, VITTORIO;ALINARI, LAPO;PILERI, STEFANO;BACCARANI, MICHELE
2008
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.